- Home
- AXSM vs GLBE Comparison
AXSM vs GLBE Comparison
Compare AXSM & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- GLBE
- Stock Information
- Founded
- AXSM 2012
- GLBE 2013
- Country
- AXSM United States
- GLBE Israel
- Employees
- AXSM N/A
- GLBE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- GLBE Computer Software: Prepackaged Software
- Sector
- AXSM Health Care
- GLBE Technology
- Exchange
- AXSM Nasdaq
- GLBE Nasdaq
- Market Cap
- AXSM 5.1B
- GLBE 5.3B
- IPO Year
- AXSM 2015
- GLBE 2021
- Fundamental
- Price
- AXSM $105.71
- GLBE $33.26
- Analyst Decision
- AXSM Strong Buy
- GLBE Strong Buy
- Analyst Count
- AXSM 16
- GLBE 14
- Target Price
- AXSM $170.50
- GLBE $49.00
- AVG Volume (30 Days)
- AXSM 694.5K
- GLBE 1.6M
- Earning Date
- AXSM 08-04-2025
- GLBE 08-13-2025
- Dividend Yield
- AXSM N/A
- GLBE N/A
- EPS Growth
- AXSM N/A
- GLBE N/A
- EPS
- AXSM N/A
- GLBE N/A
- Revenue
- AXSM $432,157,000.00
- GLBE $796,773,000.00
- Revenue This Year
- AXSM $62.84
- GLBE $27.03
- Revenue Next Year
- AXSM $60.02
- GLBE $24.56
- P/E Ratio
- AXSM N/A
- GLBE N/A
- Revenue Growth
- AXSM 72.16
- GLBE 33.20
- 52 Week Low
- AXSM $72.21
- GLBE $26.64
- 52 Week High
- AXSM $139.13
- GLBE $63.69
- Technical
- Relative Strength Index (RSI)
- AXSM 48.53
- GLBE 54.43
- Support Level
- AXSM $99.75
- GLBE $31.43
- Resistance Level
- AXSM $106.60
- GLBE $32.89
- Average True Range (ATR)
- AXSM 3.11
- GLBE 0.91
- MACD
- AXSM 0.10
- GLBE 0.25
- Stochastic Oscillator
- AXSM 44.39
- GLBE 73.57
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GLBE Global-E Online Ltd.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.